Leading Therapeutic Molecules Target Transcription Factors Binding to Repressor Region in FXN Gene
Objective: To investigate interactions of transcription factors (TFs) binding to repressor region located upstream to FXN gene with leading therapeutic molecules. Background: Low levels of…PONTINE AND EXTRAPONTINE MYELINOLYSIS PRESENTING AS ACUTE PARKINSONISM
Objective: To report a patient with acute onset parkinsonism due to extrapontine myelinosis. Background: Osmotic demyelinating diseases of the central nervous system appear to be…Predictors of short-term anxiety outcome after subthalamic stimulation in Parkinson’s Disease
Objective: To identify clinical predictors of the effect of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s Disease (PD). Background: STN-DBS is a…Frequency of non-motor symptoms in GBA-PD may differ in carriers of mild vs. severe pathogenic variants
Objective: Parkinson's disease (PD) patients with pathogenic variants in the GBA (glucocerebrosidase) gene (GBA-PD) were reported to exhibit a younger age at onset, faster progression…Involving people with lived experience of Parkinson’s in trial design: the EJS ACT-PD initiative
Objective: To maximally involve people with the lived experience of Parkinson’s in the design of the first multi-arm multi-stage (MAMS) trial for disease modifying therapies…Deleterious GRN mutations: a new player in the etiology of Lewy body dementia
Objective: In this study we investigated the association of GRN damaging mutations in the etiology of Lewy body dementia. Background: Lewy body dementia (LBD) is…Automated quantification of facial bradykinesia through video in de-novo Parkinson’s disease
Objective: The purpose of this study was therefore to develop a fully automatic video-based hypomimia assessment tool and estimate the prevalence and characteristics of hypomimia…Asymmetric midbrain atrophy in a patient with progranulin-related FTLD
Objective: We describe an atypical imaging finding in a patient with corticobasal syndrome (CBS) and a genetic diagnosis of frontotemporal lobar dementia (FTLD) associated with…Functional Rating Scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington’s disease: The importance of the patient voice in scale development
Objective: Use focus groups, a Delphi panel, and multiple iterations of cognitive pretesting to develop a patient-reported outcome (PRO) measure of function in Huntington’s disease…Clinical,imaging and genetic correlations in a Neuronal Brain Iron accumulation cohort from India
Objective: To correlate, clinical and magnetic resonance imaging (MRI) characteristics, of patients with neurodegeneration with brain iron accumulation (NBIA), with genetics and establish genotype-phenotype correlations…
- « Previous Page
- 1
- …
- 800
- 801
- 802
- 803
- 804
- …
- 1942
- Next Page »